Localized hepatic tuberculosis (LHTB) is difficult to diagnose preoperatively, and most cases of LHTB are diagnosed based on pathological findings. A relationship between imaging features and the pathological stage of hepatic tuberculosis (TB) has recently been reported, which could aid in the diagnosis of hepatic TB. We herein present a case study of a patient with LHTB diagnosed postoperatively who demonstrated imaging changes due to the progression of TB. An awareness of the presence of LHTB might have permitted a preoperative diagnosis. This is the first report of an LHTB patient who exhibited imaging changes during the course of the disease.
Introduction
Although the incidence of tuberculosis (TB) has decreased in the past decades, the recent increase in the incidence of TB is associated with the acquired immunodeficiency syndrome (AIDS) epidemic, increases in intravenous drug abuse and a rise in the number of immunocompromised patients (1, 2) . TB infection can affect any organ. Miliary hepatic TB is common (3), whereas localized hepatic TB (LHTB), which is defined in this article as tuberculous hepatic involvement without evidence of extrahepatic TB, is rare (4) .
LHTB involves no specific symptoms, laboratory abnormalities or imaging features; therefore, it is difficult to diagnose this condition preoperatively (5) . However, because anti-TB therapy (ATT) is usually effective in cases of hepatic TB (6) , unnecessary surgery can be avoided if LHTB is diagnosed early.
Imaging findings change with the pathological stage of hepatic TB (7) (8) (9) . Hence, a more thorough understanding of the relationship between the imaging findings and the pathologic stage of TB may help in establishing the correct diagnosis in patients with hepatic TB (8) .
In this study, we describe a case of LHTB in which a central, non-enhancing area on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) appeared over a short period, which may have reflected the development of caseous necrosis. To the best of our knowledge, this is the first report of an LHTB patient showing imaging changes caused by the progression of TB during the course of the disease.
Case Report
A hypertensive 75-year-old man with chronic hepatitis C (CHC) was treated with pegylated-interferon and ribavirin and achieved a sustained virological response (SVR) in 2009. Subsequently, he continued to visit our hospital regularly. No hepatic masses were observed on a computed tomography (CT) scan performed in January 2011. In January 2012, an abdominal CT scan revealed a low-density lesion measuring 1.5 cm in segment 5/6 that displayed arterial enhancement without distinct washout in the portal venous phase (Fig. 1a-c) . In February 2012, EOB-MRI indicated that the size of this mass lesion was the same as that observed on the CT scan. The lesion was hypointense on T1-weighted images and hyperintense on T2-weighted images. The perfusion of the lesion, as assessed on EOB-MRI, was similar to that observed on the CT scan (Fig. 1d, e) . How- ever, a small non-enhancing area appeared in the center of this lesion in all vascular phases. In the hepatobiliary phase, the lesion had low signal intensity ( Fig. 1f ) and was slightly smaller than the arterially enhancing area. The lesion was also hyperintense on diffusion-weighted (DW) images, and the hepatic mass displayed homogeneous hypoechoic echogenicity on abdominal ultrasonography.
The patient was asymptomatic, and a chest X-ray was normal. Laboratory testing revealed only mild elevation in the alkaline phosphatase (ALP) level (Table) . The α-fetoprotein (AFP) and prothrombin values induced by vitamin K absence-II (PIVKA-II) were within the normal limits. We diagnosed the lesion as hepatocellular carcinoma (HCC), and partial hepatectomy was performed in March 2012. A histological examination of the resected hepatic mass lesion revealed caseous necrosis surrounded by granulomas, thereby establishing the diagnosis of TB (Fig. 2a, b) . Acidfast bodies were not identified. The patient had had no contact with any other TB patients. CT scans of the chest and abdomen, endoscopic gastroduodenoscopy and colonoscopy did not show any extrahepatic tuberculous involvement. Based on these results, we diagnosed the hepatic mass to be LHTB. ATT was not performed because active TB involvement was not detected after surgery. No tuberculous lesions have been observed since the operation.
Discussion
Hepatic TB is classified into three forms: miliary, diffuse and localized hepatic (10) (11) (12) (13) . The miliary form is common, whereas the localized hepatic form is rare. This case was categorized as the localized hepatic form of the disease, and there was only one hepatic tuberculoma, which is rare.
It is difficult to accurately diagnose LHTB because it is a rare disease without specific symptoms, laboratory abnormalities or imaging features. Oliva et al. reported 23 cases of LHTB; in 20 of the 23 patients, the LHTB lesions were preoperatively misdiagnosed as carcinoma of the liver or a liver abscess (14) . Common symptoms of hepatic TB include fever, weight loss and abdominal pain, which are nonspecific (6, 10, 15, 16) . A common laboratory abnormality is an elevated ALP level (5, 6, 14, 16, 17) . Imaging studies show various non-specific features. In most cases of LHTB, a histological examination is required to make a correct diagnosis (5, 6 ). In the current case, the patient was asymptomatic, and the only abnormal laboratory result was slight elevation of ALP. Based on the imaging findings, HCC, an inflammatory pseudotumor of the liver, hepatic adenoma and a hepatic abscess were considered in the differential diagnosis. Within this preoperative differential, we suspected HCC because of the patient's previous history of SVR for hepati- tis C virus (HCV), the arterial enhancement on CT/MRI and the low signal intensity on hepatobiliary-phase EOB-MRI. We considered conducting an ultrasonography-guided needle biopsy to confirm the diagnosis; however, we did not perform this procedure due to the 2.7% risk of needle track seeding following biopsies of HCC lesions (18) . After the surgery, we were finally able to accurately diagnose LHTB based on the histopathology. Recently, a relationship between imaging features and the pathological stage of hepatic TB was reported (7-9). Cao et al. reported that there is a relationship between the findings of contrast-enhanced ultrasonography (CEUS) and the pathological features of hepatic TB (8) . In summary, during the early stage of granuloma formation, focal sinusoid destruction or congestion leads to increased arterial perfusion and decreased portal perfusion, which present as arterial enhancement and washout during the portal phase. Under conditions of disease progression, the development of granulomas and caseous necrosis results in decreased arterial and portal perfusion and the appearance of hypo-to nonenhancing lesions with an enhancing rim, caused by inflammatory hyperemia in the normal hepatic sinusoids (8) . In this case, arterial enhancement of the entire hepatic mass lesion without apparent washout in the portal venous phase was detected on CT (Fig. 1a-c) . On EOB-MRI performed one month after the CT scan, a non-enhancing area appeared within the lesion (Fig. 1e) . This change was likely due to the progression of hepatic TB and indicates that signs of exudative inflammation were replaced with granulomas and caseous necrosis. The area of caseous necrosis was seen as a small non-enhancing area on the EOB-MRI scan (black zone in Fig. 1g ). Micro-arteries also proliferated within the granulomatous tissue (Fig. 2c) , which presented as an early enhancing area in the arterial phase and as hypointensity in the hepatobiliary phase (gray zone in Fig. 1g ). The sinusoid in the normal hepatic tissue surrounding this lesion was dilated due to lymphocytic infiltration (Fig. 2d) , seen as an early enhancing area in the arterial phase and as isointensity in the hepatobiliary phase (white zone in Fig. 1g ). To the best of our knowledge, this is the first report of an LHTB patient with imaging changes caused by the progression of TB during the course of the disease. An accurate interpretation of this change might have facilitated our ability to make an accurate preoperative diagnosis of LHTB. It is very important to be aware of LHTB and consider this disease in the differential diagnosis during evaluations of patients with hepatic mass lesions.
ATT is universally effective in cases of LHTB (6). Chong et al. described an algorithm for evaluating patients with suspected hepatobiliary TB (19) . According to this algorithm, surgery should be considered if medical or other therapy fails. In the present case, we first suspected that the hepatic mass lesion was HCC; partial hepatectomy was therefore performed, and the correct diagnosis was established postoperatively. Postoperative ATT was not administered because there was no obvious involvement of other organs. No recurrence of TB has been observed since the surgery.
Clinicians should thus be aware of the possibility of LHTB when examining patients with hepatic lesions. In particular, it is necessary to consider LHTB in the differential diagnosis when imaging changes are detected.
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